Cargando…
A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative diseases. Many studies have demonstrated that the release of NLRP3 inflammasome-mediated proinflammatory cytokines by the excessive activation of microglia is associated with the pathogenesis of AD and PD and...
Autores principales: | Lee, Jun Ho, Kim, Hong Jun, Kim, Jong Uk, Yook, Tae Han, Kim, Kyeong Han, Lee, Joo Young, Yang, Gabsik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866084/ https://www.ncbi.nlm.nih.gov/pubmed/33525754 http://dx.doi.org/10.3390/ijms22031324 |
Ejemplares similares
-
Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout
por: Lee, Jun Ho, et al.
Publicado: (2022) -
Natural Products as the Potential to Improve Alzheimer’s and Parkinson’s Disease
por: Kim, Sung Wook, et al.
Publicado: (2023) -
Improvement Effect of Soyeom Pharmacopuncture on Gout via NLRP3 Inflammasome Regulation
por: Kim, Sung Wook, et al.
Publicado: (2022) -
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
por: Han, Qiu-Qin, et al.
Publicado: (2023) -
Loganin Prevents Hepatic Steatosis by Blocking NLRP3 Inflammasome Activation
por: Jang, Joo Hyeon, et al.
Publicado: (2023)